Evidence map›Paper›PMID 42646471›Full record

ArticleMarine drugs2026

Cytotoxic Activity and In Silico Study of Secondary Metabolites Derived from

Yuni Elsa Hadisaputri, Nafisa Nurfatia Hidayat, Tutik Murniasih, Ariyono Hadi, Mutakin Mutakin, Nunung Yuniati, Yonathan Asikin, Elin Julianti

Abstract read
In one paragraph

Article in Marine drugs, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuni Elsa HadisaputriDepartment of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor 45363, Indonesia.ORCID 0000-0002-8087-9152
Nafisa Nurfatia HidayatDepartment of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor 45363, Indonesia.
Tutik MurniasihResearch Center for Vaccine and Drugs, Research Organization for Health, National Research and Innovation Agency (BRIN), Bogor 16911, Indonesia.ORCID 0000-0001-7971-2884
Ariyono HadiResearch Center for Vaccine and Drugs, Research Organization for Health, National Research and Innovation Agency (BRIN), Bogor 16911, Indonesia.ORCID 0000-0002-7120-9499
Mutakin MutakinDepartment of Pharmaceutical Analysis and Medicinal Chemistry, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor 45363, Indonesia.ORCID 0000-0003-4124-1727
Nunung YuniatiLaboratory of Pharmacology and Toxicology, Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.
Yonathan AsikinDepartment of Bioscience and Biotechnology, Faculty of Agriculture, University of the Ryukyus, Nishihara 903-0213, Japan.
Elin JuliantiDepartment of Pharmacochemistry, School of Pharmacy, Institut Teknologi Bandung, Bandung 40132, Indonesia.ORCID 0000-0002-5504-6140

Funding

Indonesia Endowment Fund for Education Contract No. 4303/ 83/ DT.03.08/ 2025 and 3927/ UN6.RKT/HK.07.00/2025; 4602/UN6.3.1/PT.00/2025
6 · The paper itself

Abstract

Breast cancer remains a major global health burden.

Indexed as

Antineoplastic AgentsPoriferaAlkaloidsAnimalsComputer SimulationFemaleHumansMDA-MB-231 CellsMolecular Docking SimulationQuinonesSecondary MetabolismSesquiterpenesSteroidsTandem Mass SpectrometryTerpenesAlkaloidsAntineoplastic AgentsilimaquinoneQuinonesSesquiterpenesSteroidsTerpenes5-epi-illimaquinonebreast cancercalciferolcytotoxicityDactylospongia elegansMDA-MB-231

Identifiers

PMID42646471
PMCPMC13514943

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.